期刊文献+

血浆N端B型脑钠肽前体及左房容积与房颤导管射频消融术后复发的相关性分析 被引量:3

Correlation analysis of N-terminal pro-brain natriurctic peptide and left atrial volume with recurrence after radiofrequency catheter ablation of atrial fibrillation
下载PDF
导出
摘要 目的研究探讨血浆N端B型脑钠肽前体(NT-proBNP)及左房容积(LAV)与房颤患者房颤导管射频消融术后复发的相关性。方法选择2017年5月~2018年1月在中国科学技术大学附属第一医院进行治疗的阵发性心房颤动患者106例为研究对象,所有患者均进行房颤导管射频消融术,采用化学发光法检测术前血浆NTproBNP水平,采用经食道心脏超声测量患者的LAV。术后随访3个月,根据是否复发将患者分为复发组和非复发组,采用Logistic多因素回归分析房颤导管射频消融术后复发的危险因素。结果术后随访观察显示,术后有16例复发患者,复发率为14.68%。复发组患者的血浆NT-proBNP及LAV均高于非复发组,差异有统计学意义(P <0.05)。Logistic多因素回归分析显示,血浆NT-proBNP及LAV为阵发性房颤导管射频消融术后复发的独立危险因素(P <0.05)。结论阵发性房颤导管射频消融术后复发患者的术前血浆NT-proBNP及LAV是术后复发的独立危险因素,术前检测血浆NT-proBNP及LAV有助于预测患者术后的复发情况。 Objective To investigate the correlation of N-terminal pro-brain natriurctic peptide (NT-proBNP) and left atrial volume (LAV) with the recurrence after atrial fibrillation catheter radiofrequency ablation in patients with atrial fibrillation. Methods One hundred and six patients with paroxysmal atrial fibrillation treated in First Affiliated Hospital of University of Science and Technology of China from May 2017 to January 2018 were selected as the research subjects, all patients were performed radiofrequency ablation of atrial fibrillation catheter. The plasma NT-proBNP level before operation was detected by chemiluminescent immunoassay, LAV of the patients was measured by transesophageal echocardiography. Three months was followed-up after operation, according to whether recurrence occurred, the patients were divided into recurrence group and non-recurrence group. Logistic multivariate regression analysis was used to analyze the risk factors for recurrence after radiofrequency catheter ablation of atrial fibrillation. Results Follow-up observation showed that 16 cases recurred after operation, and the recurrence rate was 14.68%. The plasma NT-proBNP and LAV of the recurrence group were higher than those of the non-recurrence group, the differences were statistically significant (P 〈 0.05). Multivariate Logistic regression analysis showed that plasma NT-proBNP and LAV were independent risk factors for recurrence after radiofrequency catheter ablation of paroxysmal atrial fibrillation (P 〈 0.05). Conclusion The levels of plasma NT-proBNP and LAV before operation in patients with recurrent atrial fibrillation after radiofrequency catheter ablation are independent risk factors for recurrence after operation, detection of plasma NT-proBNP and LAV before operation can help predict the recurrence of patients after operation.
作者 郭飞 徐健 苏浩 朱红军 陈康玉 朱静 GUO Fei;XU Jian;SU Hao;ZHU Hongjun;CHEN Kangyu;ZHU Jing(Department of Cardiology,the First Affiliated Hospital of University of Science and Technology of China Anhui Provincial Hospital,Anhui Province,Hefei 230001,China)
出处 《中国医药导报》 CAS 2018年第32期63-66,共4页 China Medical Herald
基金 安徽省中央引导地方科技发展专项项目(2017070802D145)
关键词 心房颤动 房颤导管射频消融术 术后复发 危险因素 Atrial fibrillation Radiofrequency catheter ablation of atrial fibrillation Postoperative recurrence Risk factor
  • 相关文献

参考文献13

二级参考文献81

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1397
  • 2高大中,王春彬,赵江龙,王勇,高翠菊,殷跃辉.心房颤动1533例病因及治疗策略变化分析[J].中国实用内科杂志,2007,27(19):1517-1519. 被引量:24
  • 3Authors/Task Force Members, Camm AJ, Lip GY, et al. 2012 focused update of the ESC Guidlines for the management of atrial fibrillation An update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association[J]. Europace, 2012, 14(10): 1385-1413.
  • 4Mak GS, Demaria A, Clopton P, eta]. Utility of B-natri peptide in the evaluation of left vetricular diasrolic funct, comparison with tissue Doppler imaging recdrdings[J].Am Heart,2 004,148(2): 895-902.
  • 5Linseen GC, Rienstra M, Jaarsma T, et a]. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction[J].Eur HeaFt Fail, 2011,12(6) : 3-5.
  • 6Yamada T, Murakami Y, Okade T, et al. Plasma atrial natriuretic peptide and brain natriuretic peptide levels inloneatrial fibrillation[J]. Am Coll Cardia1,2005,45(3)..82-86.
  • 7Data T, Yamane T, Inanda K, eta]. Plasma brain natriuretic peptides concentration inpatients undergoing pulmonary Vein isolation[J]. Heart, 2006,92(6): 1623-1627.
  • 8Oral H, Christoph S, Chugh A, et a]. Catheter ablation for paroxysmal atrial fibrillation segmental pulmonary vein ostial ablation versus ieft atrial ablation[J]. Circulation,2003,108(23):2355 -2360.
  • 9January CT,Wann LS,Alpert JS,et al.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society[J].Circulation,2014;130(23):e199.
  • 10Calkins H,Heinz H,Cappato R,et al.HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation:recommendations for patient selection,procedural techniques,patient management and follow-up,definitions,endpoints,and research trial design[J].Heart Rhythm,2012;9:632-96.

共引文献69

同被引文献35

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部